Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency

Creative Commons License

Farmer J., Foldvari Z., Ujhazi B., De R., Chen K., Bleesing J., ...More

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, vol.7, no.6, pp.1970-1989, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 7 Issue: 6
  • Publication Date: 2019
  • Doi Number: 10.1016/j.jaip.2019.02.038
  • Journal Name: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1970-1989
  • Keywords: Recombination activating gene (RAG), Severe combined immunodeficiency (SCID), Immune dysregulation, Autoimmune cytopenias, Hematopoietic stem cell transplantation (HSCT), SEVERE COMBINED IMMUNODEFICIENCY, RECOMBINATION ACTIVITY, GRANULOMATOUS-DISEASE, CLINICAL PHENOTYPES, VACCINE-STRAIN, OMENN SYNDROME, MUTATIONS, CYTOPENIAS, RITUXIMAB, GENE
  • Erciyes University Affiliated: Yes

Abstract

BACKGROUND: Although autoimmunity and hyperinflammation secondary to recombination activating gene (RAG) deficiency have been associated with delayed diagnosis and even death, our current understanding is limited primarily to small case series.